Cynthia X Ma

37PUBLICATIONS
378CO-AUTHORS
Molecular targetsCancer diagnosisTumour immunologyPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|May 26, 2026
Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

|Apr 17, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

|Feb 06, 2026
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial.

Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang

|Jan 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Tim Kong, Alex Mabry, Maureen Highkin

|Aug 25, 2025
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.

Lorenzo Gerratana, Carolina Reduzzi, Yue Ren

|Jul 29, 2025
Targeting Triple-Negative Breast Cancer with Momordicine-I for Therapeutic Gain in Preclinical Models.

Kousik Kesh, Ellen T Tran, Ruchi A Patel

Pageof 7

Frequent Collaborators

8 joint publications

Foluso O Ademuyiwa

7 joint publications

Li Ding

6 joint publications

Sherri R Davies

5 joint publications

Wenge Zhu